HR vs MPT Stock Comparison

Healthcare Realty Trust and Medical Properties Trust Prices as of Oct 26, 2026 Peers: Industry group

Head to Head

8 decided of 12

Healthcare Realty Trust leads on 6 of the 12 questions below (Healthcare Realty Trust 6, Medical Properties Trust 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionHRMPTLeader
Larger companyMarket capitalisation $6.08B $1.66B HR
Cheaper on earningsLower P/E, profitable companies only -69.9x -13.2x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 70.0x –
Faster revenue growthRevenue growth, trailing twelve months -6.3% +5.5% MPT
More profitableNet margin, trailing twelve months -7.6% -12.6% HR
Better return on capitalReturn on invested capital — 2.7% –
Less leveragedLower net debt / EBITDA — 13.1x –
Higher dividend yieldTrailing dividend yield 0.06% 0.12% MPT
Better 1-year returnPrice return, last 12 months -3.7% -45.4% HR
Better 5-year returnAnnualised price return, 5 years -11.6%/yr -33.4%/yr HR
Less volatileAnnualised volatility, 1 year 20.0% 38.1% HR
Higher overall scoreMean of the five percentile scores vs peers 42/100 36/100 HR

Percentile Scorecard

HRMPT

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHRMPT
Valuation 38 #90 of 145 60 #58 of 145
Growth 55 #64 of 142 49 #73 of 142
Profitability 30 #95 of 136 27 #100 of 136
Financial Health 47 #74 of 139 12 #123 of 139
Shareholder Returns 41 #78 of 131 32 #89 of 131
Overall 42 36
  • HR ranked among 149 companies in Property REITs
  • MPT ranked among 149 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHRMPTSPY
1 month -0.5%-21.6% -0.8%
3 months -16.5%-41.7% +3.5%
6 months -2.2%-45.4% +7.0%
Year to date +6.0%-44.0% +12.2%
1 year -3.7%-45.4% +13.0%
3 years +27.2%-42.9% +86.3%
3 years, per year +8.3%-17.0% +23.1%
5 years -46.0%-86.9% +68.6%
5 years, per year -11.6%-33.4% +11.0%
10 years -44.8%-80.7% +258.0%
10 years, per year -5.8%-15.2% +13.6%

Risk

MeasureHRMPTSPY
Volatility, 1Y 20.0%38.1% 12.7%
Downside volatility, 1Y 20.0%39.5% 12.7%
Beta vs S&P 500, 1Y 0.110.42 1.00
Return / volatility, 1Y -0.19-1.19 1.02
Max drawdown, 5Y -61.6%-89.1% -25.4%
From 52-week high -17.9%-53.5% -1.8%
52-week high $21.89$6.02 $779.14
52-week low $16.34$2.62 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHRMPT
P/E now vs peer median -70.8xmedian 27.4x -13.3xmedian 27.4x
P/S now vs peer median 5.4xmedian 4.2x 1.7xmedian 4.2x
EV/EBITDA now vs peer median —median 14.2x 15.4xmedian 14.2x
P/FCF now vs peer median 49.8xmedian 23.2x 96.4xmedian 23.2x
P/B now vs peer median 1.4xmedian 1.3x 0.4xmedian 1.3x
PEG now vs peer median -3.84median 2.11 0.39median 2.11

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHRMPT
Revenue $1.14B $1.00B
Net income -$87.96M -$124.81M
Free cash flow $123.68M $17.36M
EPS (diluted) $-0.25 $-0.21
Cash & equivalents $18.99M $425.00M
Total debt $4.17B $9.66B
Shares (diluted) 342.30M 597.72M
Enterprise value $5.96B -$213.61M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHRMPT
P/E -70.8x -13.3x
P/FCF 49.8x 96.4x
P/Operating cash flow 14.0x 7.7x
P/S 5.4x 1.7x
P/B 1.4x 0.4x
P/Tangible book 1.4x 0.4x
EV/EBITDA – 15.4x
EV/EBIT – 27.3x
EV/Revenue 9.0x 10.9x
EV/FCF 83.3x 628.5x
EV/Operating cash flow 23.4x 50.5x
PEG (3Y EPS CAGR) -3.84 0.39

Growth

14 metrics
MetricHRMPT
Revenue growth (1Y) -6.3% 5.5%
Revenue CAGR (3Y) -4.5% -12.3%
Gross profit growth (1Y) – –
Gross profit CAGR (3Y) – –
Operating income growth (1Y) – –
Operating income CAGR (3Y) – –
Net income growth (1Y) 78.5% 92.4%
Net income CAGR (3Y) 21.1% -34.1%
EPS growth (1Y) 77.9% 92.3%
EPS CAGR (3Y) 18.4% -34.2%
Operating cash flow growth (1Y) -5.8% 26.0%
Operating cash flow CAGR (3Y) 2.2% -32.3%
Free cash flow growth (1Y) -8.9% 135.2%
Free cash flow CAGR (3Y) 314.6% 30.9%

Profitability

14 metrics
MetricHRMPT
Gross margin – –
EBITDA margin – 70.7%
Operating margin – –
Pretax margin – -12.8%
Net margin -7.6% -12.6%
FCF margin 10.8% 1.7%
Operating cash flow margin 38.5% 21.6%
Return on equity -2.0% -2.7%
Return on assets -1.0% -0.8%
Return on invested capital – 2.7%
Return on capital employed – –
Asset turnover 0.1x 0.1x
Cash conversion (OCF / net income) -5.0x -1.7x
Stock comp / revenue 1.8% 0.9%

Financial Health

11 metrics
MetricHRMPT
Debt / assets 46.3% 65.5%
Debt / equity 1.0x 2.1x
Net debt / EBITDA – 13.1x
Debt / FCF 33.7x 556.6x
Liabilities / assets 52.6% 69.2%
Equity / assets 47.4% 30.8%
Interest coverage – 0.8x
Current ratio – –
Quick ratio – –
Cash ratio – –
Altman Z-score – –

Shareholder Returns

7 metrics
MetricHRMPT
Dividend yield 5.3% 12.9%
Net buyback yield 2.9% –
Shareholder yield 8.3% 12.9%
Payout ratio (earnings) -381.2% -160.6%
Payout ratio (FCF) 271.1% 1,155%
Dividend growth (1Y) -23.8% -27.5%
Dividend CAGR (3Y) -7.7% -34.0%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHRMPT
Forward P/E – 70.0xFY2026
EPS, next fiscal year $-0.11FY2026 $0.04FY2026
EPS growth, the year after – -125.0%
Revenue, next fiscal year $1.17BFY2026 $1.05BFY2026
Revenue growth, next FY -0.7%FY2026 +8.1%FY2026
Revenue growth, the year after -8.9% -5.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersHRMPT
Held by institutions 100.0% 60.8%
Institutions holding 458 486
Change in shares held, QoQ +0.8% +5.2%
Institutions buying 225 222
Institutions selling 145 169
Buyers to sellers 1.55 1.31

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

HRMPT
HR 1.00 0.32
MPT 0.32 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, HR and MPT?

Healthcare Realty Trust (HR) is the largest by market capitalisation: Healthcare Realty Trust (HR) $6.08B, Medical Properties Trust (MPT) $1.66B.

Which company is growing faster?

Medical Properties Trust (MPT) grew revenue fastest over the trailing twelve months: Healthcare Realty Trust (HR) -6.3%, Medical Properties Trust (MPT) +5.5%.

Which company is more profitable?

Healthcare Realty Trust (HR) has the highest net margin (Healthcare Realty Trust (HR) -7.6%, Medical Properties Trust (MPT) -12.6%).

Which stock has performed better?

Over the past year Healthcare Realty Trust (HR) returned the most: Healthcare Realty Trust (HR) -3.7%, Medical Properties Trust (MPT) -45.4%. Over five years, Healthcare Realty Trust (HR) compounded fastest (Healthcare Realty Trust (HR) -11.6%/yr, Medical Properties Trust (MPT) -33.4%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Medical Properties Trust (MPT) has the highest dividend yield: Healthcare Realty Trust (HR) 0.06%, Medical Properties Trust (MPT) 0.12%.

Which stock is riskier?

By one-year price volatility, Healthcare Realty Trust (HR) has been the steadiest (Healthcare Realty Trust (HR) 20.0%, Medical Properties Trust (MPT) 38.1%). Volatility measures how widely the price swings, not the risk of the business.

Do HR and MPT move together?

Their daily returns over the past year have a correlation of 0.32, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, HR and MPT?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Healthcare Realty Trust (HR) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.